
Co-Diagnostics CODX
$ 1.34
-17.79%
Quarterly report 2026-Q1
added 05-14-2026
Co-Diagnostics Depreciation & Amortization 2011-2026 | CODX
Annual Depreciation & Amortization Co-Diagnostics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.11 M | 1.38 M | 1.23 M | 1.28 M | 335 K | 139 K | 65.9 K | 50.8 K | 45.8 K | 37.5 K | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.38 M | 37.5 K | 567 K |
Quarterly Depreciation & Amortization Co-Diagnostics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 255 K | 267 K | 291 K | 280 K | - | 351 K | 338 K | 331 K | - | 296 K | 305 K | 316 K | - | 312 K | 424 K | 247 K | - | 233 K | 139 K | 67 K | - | 35.5 K | 25.2 K | 20.7 K | - | 17 K | 16.1 K | 13.7 K | - | 12.6 K | 12.6 K | 12.4 K | - | 12.4 K | 11.1 K | 9.73 K | - | 7.3 K | 8.86 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 424 K | 7.3 K | 156 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 17.26 | -7.0 % | $ 181 M | ||
|
Fulgent Genetics
FLGT
|
24.9 M | $ 15.78 | -2.53 % | $ 477 M | ||
|
Agilent Technologies
A
|
321 M | $ 112.09 | -1.02 % | $ 34.1 B | ||
|
Castle Biosciences
CSTL
|
40.8 M | $ 19.05 | 0.9 % | $ 552 M | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
354 M | $ 139.97 | -2.28 % | $ 22.3 B | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
15 M | $ 19.83 | -3.22 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 94.74 | -2.0 % | $ 6.39 B | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 419.82 | 0.16 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 043.89 | 0.19 % | $ 21.5 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 3.6 | -0.69 % | $ 333 M | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
36.1 M | $ 8.28 | -0.96 % | $ 1.06 B | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
7.62 M | $ 18.46 | -2.48 % | $ 413 M | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 157.18 | -1.33 % | $ 7.79 B | ||
|
Natera
NTRA
|
16.7 M | $ 186.22 | -5.43 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 25.27 | -0.94 % | $ 24 B | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
39.7 M | $ 92.95 | -5.79 % | $ 11.7 B | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 5.73 | -1.55 % | $ 239 M | ||
|
Personalis
PSNL
|
10 M | $ 6.47 | -3.64 % | $ 577 M | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
488 M | $ 117.95 | 0.73 % | $ 9.73 B | ||
|
Soleno Therapeutics
SLNO
|
2.02 M | $ 52.99 | -0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 49.3 | -6.89 % | $ 2.95 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.31 | -4.04 % | $ 5.31 M | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 251.18 | -1.12 % | $ 20.9 B | ||
|
Thermo Fisher Scientific
TMO
|
1.05 B | $ 439.31 | -1.97 % | $ 166 B | ||
|
Celcuity
CELC
|
167 K | $ 134.9 | 0.13 % | $ 6.31 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
88.1 M | $ 331.34 | -0.56 % | $ 19.7 B | ||
|
Neogen Corporation
NEOG
|
119 M | $ 8.27 | -1.9 % | $ 1.79 B |